• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Non-redundant tumour supressor functions of transforming growth factor beta in breast cancer.

作者信息

Azhar M

机构信息

Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati Medical centre, 231 Albert Sabin Way, Cincinnati, Ohio 45267-0524, USA.

出版信息

J Biosci. 2001 Mar;26(1):9-12. doi: 10.1007/BF02708975.

DOI:10.1007/BF02708975
PMID:11255508
Abstract
摘要

相似文献

1
Non-redundant tumour supressor functions of transforming growth factor beta in breast cancer.转化生长因子β在乳腺癌中的非冗余肿瘤抑制功能
J Biosci. 2001 Mar;26(1):9-12. doi: 10.1007/BF02708975.
2
Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.转化生长因子-β信号通路基因的一致性表观遗传沉默在乳腺癌发生早期就会出现。
Cancer Res. 2007 Dec 15;67(24):11517-27. doi: 10.1158/0008-5472.CAN-07-1284.
3
Cancer: new-age tumour suppressors.
Nature. 2002 May 16;417(6886):235-7. doi: 10.1038/417235a.
4
CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.CBL 通过抑制 TGF-β 信号的肿瘤抑制活性来增强乳腺癌的形成。
Oncogene. 2012 Dec 13;31(50):5123-31. doi: 10.1038/onc.2012.18. Epub 2012 Feb 6.
5
Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.转化生长因子βⅠ型受体的Smad结合缺陷突变体增强乳腺癌细胞系的肿瘤发生但抑制其转移
Cancer Res. 2004 Jul 1;64(13):4523-30. doi: 10.1158/0008-5472.CAN-04-0030.
6
Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.通过转化生长因子-β中和抗体逆转人乳腺癌在体内的他莫昔芬耐药性
J Natl Cancer Inst. 1999 Jan 6;91(1):46-53. doi: 10.1093/jnci/91.1.46.
7
ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.ITIH5 诱导 TGF-β 超家族信号转导发生变化，涉及内皮糖蛋白，降低乳腺癌转移和肿瘤死亡的风险。
Mol Carcinog. 2018 Feb;57(2):167-181. doi: 10.1002/mc.22742. Epub 2017 Oct 30.
8
Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.抗雌激素可诱导乳腺癌中转化生长因子β介导的免疫抑制。
Cancer Res. 2010 Feb 15;70(4):1314-22. doi: 10.1158/0008-5472.CAN-09-3292. Epub 2010 Feb 9.
9
[Suppression of transforming growth factor beta 1 on malignant phenotype in HL-60 cells].[转化生长因子β1对HL-60细胞恶性表型的抑制作用]
Zhonghua Yi Xue Za Zhi. 1997 May;77(5):348-50.
10
Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.
Br J Cancer. 1991 Apr;63(4):609-14. doi: 10.1038/bjc.1991.140.

引用本文的文献

1
G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30.G15通过抑制GPR30来阻止上皮-间质转化，从而使上皮性乳腺癌细胞对阿霉素敏感。
Am J Transl Res. 2015 May 15;7(5):967-75. eCollection 2015.
2
Novel RING E3 ubiquitin ligases in breast cancer.乳腺癌中的新型RING E3泛素连接酶
Neoplasia. 2006 Aug;8(8):689-95. doi: 10.1593/neo.06469.

本文引用的文献

1
Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution.转化生长因子β3在乳腺退化的第一阶段诱导细胞死亡。
Development. 2000 Jul;127(14):3107-18. doi: 10.1242/dev.127.14.3107.
2
Effect of transforming growth factor beta 2 on oestrogen metabolism in the MCF-7 breast cancer cell line.转化生长因子β2对MCF-7乳腺癌细胞系雌激素代谢的影响。
J Clin Pathol. 2000 Apr;53(4):322-4. doi: 10.1136/jcp.53.4.322.
3
Transforming growth factor beta and its receptors: their role in breast cancer.
转化生长因子β及其受体：它们在乳腺癌中的作用。
Histopathology. 2000 Feb;36(2):178-80. doi: 10.1046/j.1365-2559.2000.00861.x.
4
Latent forms of transforming growth factor-beta 2 (TGF-beta 2) in breast cyst fluid.
Anticancer Res. 1999 Jul-Aug;19(4B):3077-82.
5
Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.转化生长因子β1在肿瘤发生的早期阶段抑制非转移性结肠癌。
Cancer Res. 1999 Jul 15;59(14):3379-86.
6
Effect of transforming growth factor-beta1 on oestrogen metabolism in MCF-7 and MDA-MB-231 breast cancer cell lines.
Oncol Rep. 1999 Jul-Aug;6(4):843-6. doi: 10.3892/or.6.4.843.
7
Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.在小鼠乳腺基质中过表达一种激酶缺陷型转化生长因子-βⅡ型受体，会导致上皮分支增加。
Mol Biol Cell. 1999 Apr;10(4):1221-34. doi: 10.1091/mbc.10.4.1221.
8
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer.转化生长因子-β1在正常人血浆中循环，在晚期转移性乳腺癌中无变化。
Clin Cancer Res. 1995 Jan;1(1):129-36.
9
TGF-beta signal transduction.转化生长因子-β信号转导
Annu Rev Biochem. 1998;67:753-91. doi: 10.1146/annurev.biochem.67.1.753.
10
Smad3 mutant mice develop metastatic colorectal cancer.Smad3基因变异的小鼠会患上转移性结直肠癌。
Cell. 1998 Sep 18;94(6):703-14. doi: 10.1016/s0092-8674(00)81730-4.